266 related articles for article (PubMed ID: 37466203)
21. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
[TBL] [Abstract][Full Text] [Related]
22. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Nandakumar V; Vaid M; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
[TBL] [Abstract][Full Text] [Related]
23. The antagonistic effect of FTO on METTL14 promotes AKT3 m
Wei R; Zhao F; Kong L; Pu Y; Li Y; Zang C
J Cancer Res Clin Oncol; 2024 Mar; 150(3):131. PubMed ID: 38491196
[TBL] [Abstract][Full Text] [Related]
24. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
25. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
26. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
Ren S; Xiao Y; Yang L; Hu Y
Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
[TBL] [Abstract][Full Text] [Related]
27. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
28. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.
Li A; Cao C; Gan Y; Wang X; Wu T; Zhang Q; Liu Y; Yao L; Zhang Q
Clin Transl Med; 2022 Jun; 12(6):e906. PubMed ID: 35678231
[TBL] [Abstract][Full Text] [Related]
29. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer.
Guan Q; Lin H; Miao L; Guo H; Chen Y; Zhuo Z; He J
J Hematol Oncol; 2022 Feb; 15(1):13. PubMed ID: 35115038
[TBL] [Abstract][Full Text] [Related]
30. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
31. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
32. Arginine methylation of METTL14 promotes RNA N
Liu X; Wang H; Zhao X; Luo Q; Wang Q; Tan K; Wang Z; Jiang J; Cui J; Du E; Xia L; Du W; Chen D; Xia L; Xiao S
Nat Commun; 2021 Jun; 12(1):3780. PubMed ID: 34145242
[TBL] [Abstract][Full Text] [Related]
33. LNC942 promoting METTL14-mediated m
Sun T; Wu Z; Wang X; Wang Y; Hu X; Qin W; Lu S; Xu D; Wu Y; Chen Q; Ding X; Guo H; Li Y; Wang Y; Fu B; Yao W; Wei M; Wu H
Oncogene; 2020 Jul; 39(31):5358-5372. PubMed ID: 32576970
[TBL] [Abstract][Full Text] [Related]
34. METTL14-Mediated m6A Modification of TNFAIP3 Involved in Inflammation in Patients With Active Rheumatoid Arthritis.
Tang J; Yu Z; Xia J; Jiang R; Chen S; Ye D; Sheng H; Lin J
Arthritis Rheumatol; 2023 Dec; 75(12):2116-2129. PubMed ID: 37327357
[TBL] [Abstract][Full Text] [Related]
35. N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma.
Wang F; Zhu Y; Cai H; Liang J; Wang W; Liao Y; Zhang Y; Wang C; Hou J
Front Oncol; 2021; 11():738406. PubMed ID: 34900689
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
[TBL] [Abstract][Full Text] [Related]
37. EGR2-mediated regulation of m
Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
[TBL] [Abstract][Full Text] [Related]
38. METTL3 and METTL14-mediated N
Shen L; Zhang C; Zhang Y; Yang Y
Reprod Biomed Online; 2023 Feb; 46(2):255-265. PubMed ID: 36517319
[TBL] [Abstract][Full Text] [Related]
39. NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m
Zhang X; An K; Ge X; Sun Y; Wei J; Ren W; Wang H; Wang Y; Du Y; He L; Li O; Zhou S; Shi Y; Ren T; Yang YG; Kan Q; Tian X
Breast Cancer Res; 2024 Jun; 26(1):94. PubMed ID: 38844963
[TBL] [Abstract][Full Text] [Related]
40. NSUN2-mediated m
Zuo S; Li L; Wen X; Gu X; Zhuang A; Li R; Ye F; Ge S; Fan X; Fan J; Chai P; Lu L
Clin Transl Med; 2023 May; 13(5):e1273. PubMed ID: 37228185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
